Press Releases

Showing 1-35 of 253

First 1 2 3 4 5 6 7 8 Next Last

2013
May
May 21	Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
May 9	Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
May 8	Abbott to Present at UBS Global Healthcare Conference
May 7	New Parenting Survey Reveals That Nearly All Moms Feel Judged on Parenting Decisions

April
April 18	Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients
April 17	Abbott Reports First-Quarter 2013 Results
April 16	Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand
April 15	Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States
April 10	Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient
April 1	Abbott Hosts Conference Call for First-Quarter Earnings

March
March 28	New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues
March 20	FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery
March 11	New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold
March 10	Abbott's Minimally Invasive MitraClip^® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery
March 7	Abbott to Present at Barclays Capital 2013 Global Healthcare Conference
March 4	Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect® Nutrition Bars

February
February 21	Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy
February 15	Abbott Declares 357th Consecutive Quarterly Dividend
February 12	New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not Doing Enough to Aid Recovery After Exercise

January
January 23	Abbott Reports Fourth-Quarter and Full-Year 2012 Results
January 21	Abbott and AbbVie Named to S&P Dividend Aristocrats Indices
January 14	Abbott and AbbVie Announce Investor Calls
January 9	New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks
January 8	Abbott Initiates Clinical Trial of Absorb™ in the United States
January 3	Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System
January 2	Abbott Completes Separation of Research-Based Pharmaceuticals Business
2012
December
December 21	Abbott and AbbVie to Present at Financial Conferences
December 17	Abbott Announces New Testosterone Test to Measure the Hormone at Low Levels
December 17	AbbVie Inc. Common Stock Approved for Listing on NYSE Euronext Paris
December 14	Abbott Declares 356th Consecutive Quarterly Dividend
December 13	New Study Shows Promising Results For Tests That Can Help Doctors Better Evaluate Potential Heart Attacks
December 7	Abbott Announces Effectiveness of AbbVie Form 10 Registration Statement

November
November 28	Abbott Board of Directors Approves Separation of AbbVie and Declares Special Dividend Distribution of AbbVie Stock
November 27	Abbott’s HUMIRA® (Adalimumab) Approved in Europe for Severe Active Pediatric Crohn’s Disease
November 13	Abbott Announces Phase 3 Hepatitis C Program Details

First 1 2 3 4 5 6 7 8 Next Last

Narrow by Year

Narrow to Show

For a different perspective on Abbott News. . .

View Abbott Feature Stories

© 2006, 2013 Abbott Laboratories, Abbott Park, Illinois, USA

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.